香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚賴 該等內容而引致的任何損失承擔任何責任。 Simcere Pharmaceutical Group Limited （股份代號：2096） 截 至2025年12月31日止年度之全年業績公告 先 聲 藥 業 集 團 有 限 公 司（「本公司」）董 事（「董 事」）會（「董事會」）欣 然 公 佈 本 公 司 連 同 其 附 屬 公 司（統 稱「本集團」）截 至2025年12月31日 止 年 度（「報告期間」）的 合 併 財 務業績，連同2024年的比較數字。報告期間的合併財務報表已獲本公司審計委員 會（「審計委員會」）審 閱 及 經 本 公 司 核 數 師 畢 馬 威 會 計 師 事 務 所 審 核。 – 1 – 財務摘要 截 至2025年12月31日止年度： 1 包含許可收入 2 本集團將經調整歸屬於本公司權益股東的利潤界定為對下列項目作出調整的歸屬於本公 司權益股東的利潤：(i)以公允價值計量且其變動計入損益的金融資產的已變現及未變現收 益╱（ ...

Financial Performance - Total revenue for the year ended December 31, 2025, was RMB 5,493,330, a decrease of 2.5% compared to RMB 5,633,410 in 2024[2] - Gross profit increased by 1.2% to RMB 684,502, with a gross margin of 12.5%, up 0.5 percentage points from 12.0% in 2024[2] - Operating profit rose by 16.3% to RMB 172,364, compared to RMB 148,179 in the previous year[6] - Profit attributable to shareholders surged by 405.8% to RMB 38,320, up from RMB 7,576 in 2024[2] - Basic and diluted earnings per share increased by 437.5% to RMB 0.43, compared to RMB 0.08 in 2024[2] - The company reported a net profit of RMB 39,302 for the year, significantly higher than RMB 4,736 in 2024[8] Assets and Liabilities - Total assets as of December 31, 2025, amounted to RMB 12,612,092, an increase from RMB 11,928,201 in 2024[10] - Total liabilities increased to RMB 8,970,825 from RMB 8,263,612 in the previous year[10] - Cash and cash equivalents rose to RMB 999,972, compared to RMB 790,586 in 2024[9] Cash Flow - Operating cash generated for the year ended December 31, 2025, was RMB 49,721 thousand, a decrease from RMB 708,088 thousand in 2024[11] - Net cash generated from operating activities for 2025 was RMB 26,657 thousand, down from RMB 678,333 thousand in 2024[11] - Net cash used in investing activities increased to RMB 168,365 thousand in 2025 from RMB 84,092 thousand in 2024[11] - Cash inflow from the disposal of property, plant, and equipment was RMB 45,622 thousand in 2025, compared to RMB 1,357 thousand in 2024[11] Revenue Segmentation - Revenue from land drilling rigs was RMB 1,945,182,000, slightly down from RMB 1,951,318,000 in the previous year, representing a decrease of 0.2%[23] - Revenue from the offshore segment increased significantly to RMB 1,518,986,000, up 76.5% from RMB 859,802,000 in 2024[23] - The Middle East region contributed RMB 2,547,130,000 to revenue, a significant increase from RMB 1,881,781,000 in 2024, marking a growth of 35.4%[24] Expenses and Costs - The total cost of sales, distribution expenses, R&D expenses, and administrative expenses for 2025 was RMB 5,522,478,000, a decrease from RMB 5,701,110,000 in 2024[32] - The total income tax expense for 2025 was RMB 31,410,000, compared to RMB 35,087,000 in 2024[35] - The company reported a net foreign exchange loss of RMB 6,165,000 in 2025, contrasting with a net gain of RMB 31,836,000 in 2024[33] Research and Development - R&D expenditures for 2025 were RMB 134,145,000, an increase from RMB 103,228,000 in 2024[32] - Government grants recognized for R&D activities amounted to RMB 23,141,000 in 2025, up from RMB 10,764,000 in 2024[31] Corporate Governance - The company has adopted the Corporate Governance Code as the basis for its corporate governance practices[125] - The company complied with all provisions of the Corporate Governance Code for the entire year ending December 31, 2025[126] - The Board will continue to review and monitor the company's corporate governance practices to maintain high standards[127] Market Performance - Revenue from the Chinese market was RMB 2,395.7 million, a year-on-year decline of 8.5%, accounting for 43.6% of total revenue[69] - Revenue from overseas markets increased by 2.7% to RMB 3,097.6 million, representing 56.4% of total revenue, with the Middle East contributing RMB 2,547.1 million, up 35.4%[70] Strategic Initiatives - The company aims to become a leading supplier of marine engineering equipment, focusing on deep-sea technology and domestic substitution strategies[95] - The company is committed to digital transformation and smart upgrades, aiming to enhance core competitiveness through intelligent equipment systems[97] - The company has made significant progress in green innovation, achieving a 65% reduction in noise and over 90% reduction in carbon emissions with its newly developed drilling equipment[92]

Financial Performance - Total revenue for the year ended December 31, 2025, was RMB 347.76 million, representing a 21.0% increase from RMB 287.36 million in 2024[5] - Gross profit decreased to RMB 104.17 million, with a gross margin of 30.0%, down from RMB 146.88 million and a gross margin of 51.1% in the previous year, reflecting a decline of 29.1%[5] - The net loss for the year was RMB 186.02 million, a 135.5% increase compared to a net loss of RMB 78.97 million in 2024, indicating a worsening financial performance[5] - Operating loss widened to RMB 179.2 million in 2025 from RMB 71.0 million in 2024, primarily due to increased sales and administrative expenses[18] - The company's operating loss for the year ended December 31, 2025, was RMB 179.25 million, compared to an operating loss of RMB 71.02 million in 2024, indicating a significant increase in losses[44] - The total net assets of the company as of December 31, 2025, amounted to RMB 731.52 million, a substantial increase from RMB 254.91 million in 2024[45] - The company has a debt-to-asset ratio of 44.7% as of December 31, 2025, indicating a moderate level of leverage[38] - The company reported a pre-tax loss of RMB 185,954,000 for 2025, compared to a loss of RMB 77,500,000 in 2024, representing an increase in losses of 139.9%[58] - The effective tax expense for 2025 was RMB 61,000, a decrease from RMB 1,472,000 in 2024, showing a reduction of 95.9%[58] Revenue Segmentation - Revenue increased from RMB 287.4 million in 2024 to RMB 347.8 million in 2025, driven by sales growth in the 51Aes, 51Sim, and 51Earth segments[19] - Revenue from the 51Aes digital twin platform was RMB 274,411,000, up from RMB 236,166,000, indicating a growth of 16.2%[54] - The 51Sim platform generated revenue of RMB 55,622,000, a 16.9% increase from RMB 47,595,000 in the previous year[54] - The 51Earth platform saw significant growth, with revenue rising to RMB 17,728,000 from RMB 3,601,000, marking an increase of 392.5%[54] Market Position and Strategy - 51Sim achieved a market share of 53.5% in the end-to-end high-level intelligent driving simulation and data platform market in China, ranking first in the industry[10] - The company plans to solidify its market position in the physical AI sector by leveraging its technological advancements in world spatial modeling, simulation training platforms, and synthetic data fuel[14] - The company plans to expand its overseas market presence in the Middle East and Southeast Asia, focusing on a light-asset model and offering multilingual API products[17] - The company aims to transition traditional project revenue towards SaaS revenue, increasing the proportion of high-value-added business[17] - The company is positioned to capitalize on the upcoming wave of physical AI, aligning its business strategy with industry trends towards understanding and adapting to three-dimensional realities[14] Research and Development - Research and development expenses rose from RMB 58.3 million in 2024 to RMB 82.3 million in 2025, mainly due to increased technical service fees[22] - R&D efforts will focus on advancing physical AI capabilities and enhancing core business operations through domestic solutions and spatial intelligence technology[16] - The company is developing a digital twin application and development platform called WDP, which offers various services for developers[83] - The company emphasizes the integration of AI and 3D Gaussian splatting technology for real-time rendering, enhancing its product offerings[77] Operational Efficiency - The company aims to enhance operational efficiency through a systematic AI transformation strategy, with over 50 AI training courses conducted throughout the year[11] - The company has set a target to limit annual human resource cost growth to no more than 10%, optimizing its workforce structure through AI leverage[12] - Employee training and development initiatives have been implemented to improve operational efficiency and R&D capabilities, with a focus on integrating advanced AI productivity tools[35] Governance and Compliance - The audit committee reviewed the financial data for the reporting period and confirmed compliance with applicable accounting standards[74] - The financial figures for the year ended December 31, 2025, have been verified by KPMG, ensuring consistency with the audited financial statements[75] - The company is committed to adhering to international financial reporting standards, enhancing transparency for investors[78] Future Outlook - The company acknowledges potential risks and uncertainties that may affect future performance, advising stakeholders to consider these factors[82] - The company plans to continue exploring new investment opportunities related to its core business to enhance service and product offerings[43] - The company is focused on developing embodied intelligence for real-world applications, enhancing its competitive edge in the market[77] Shareholder Information - The company does not recommend any dividend distribution for the years ended December 31, 2025, and 2024[66] - The company maintained a public float of at least 25% of its issued shares since the listing date[69] - The company is set to list its H-shares on December 30, 2025, under stock code 06651[78]

Financial Performance - The company reported a total revenue of HK$2,605.4 million for the year ending December 31, 2025, representing a 9.8% increase from HK$2,372.976 million in 2024[3] - The net profit for the year was HK$82.4 million, down 44.8% from HK$149.3 million in 2024[3] - Basic earnings per share decreased to 9.88 HK cents from 17.91 HK cents in 2024[3] - Adjusted EBITDA was HK$110.7 million, a slight increase of 0.1% from HK$110.6 million in 2024[3] - The group reported a profit before tax of HKD 100,251 for the year, down from HKD 168,087 in the previous year[30] - Adjusted profit for the year was HKD 79.9 million, down 8.2% from HKD 87.1 million in the previous year[69] - The total reportable segment profit for the year was HKD 136,414, a slight decrease from HKD 140,604 in 2024[30] Revenue Breakdown - Revenue from the Information Technology Products segment was HKD 1,273,579, up from HKD 1,109,716 in the previous year, representing a growth of 14.8%[21] - Revenue from the Information Technology Services segment increased to HKD 1,331,815 from HKD 1,263,260, reflecting a growth of 5.4%[21] - Revenue recognized at a point in time was HKD 1,506,458,000 for 2025, up from HKD 1,314,513,000 in 2024, reflecting a growth of 14.6%[39] - Revenue from external customers for the year ended December 31, 2025, was HKD 2,605,394,000, an increase of 9.8% compared to HKD 2,372,976,000 in 2024[35] Assets and Liabilities - Total assets increased to HKD 3,323,717 thousand in 2025, up from HKD 3,276,421 thousand in 2024, representing a growth of 1.4%[10] - Total liabilities decreased to HKD 974,899 thousand in 2025 from HKD 999,513 thousand in 2024, a reduction of 2.5%[11] - Equity attributable to shareholders increased to HKD 2,348,818 thousand in 2025, up from HKD 2,276,908 thousand in 2024, reflecting a growth of 3.2%[10] - Current assets rose to HKD 1,711,209 thousand in 2025, compared to HKD 1,662,349 thousand in 2024, indicating an increase of 2.9%[10] - Non-current assets amounted to HKD 1,612,508 thousand in 2025, slightly down from HKD 1,614,072 thousand in 2024[10] Cash Flow and Dividends - The adjusted operating cash flow showed a significant decline to HK$(68.7) million, compared to HK$124.8 million in 2024, marking a 155.1% decrease[3] - The company declared a final dividend of 3.0 HK cents per share, unchanged from the previous year[3] - The proposed final dividend for the year ended December 31, 2025, is HKD 0.03 per share, consistent with the previous year, with an additional special dividend of HKD 0.10 per share proposed for 2025[46][47] Operational Highlights - New orders amounted to HK$2,490.7 million, reflecting a 2.0% growth compared to HK$2,540.3 million in 2024[3] - The company experienced a fair value loss on investment properties of HK$1.685 million, compared to a loss of HK$2.3 million in 2024[7] - The company had unfulfilled performance obligations revenue of HKD 1,549,068,000 as of December 31, 2025, down from HKD 1,649,772,000 in 2024, indicating a decrease of 6.1%[39] - The company’s property, plant, and equipment additions amounted to HKD 17,079,000 in 2025, compared to HKD 12,818,000 in 2024, indicating a 33.5% increase[50] Market and Strategic Developments - The group has expanded its regional business by establishing offices in Malaysia and Australia, and is accelerating the application of artificial intelligence technology[75] - The group plans to enhance investment in the IT Application Innovation sector and strengthen collaboration with technology partners like Huawei[79] - The group is facing dual pressures on costs and pricing due to geopolitical tensions and increased competition in the Hong Kong market, leading to longer customer decision cycles[78] - The group aims to deepen its DevSecOps capabilities and optimize cost models while exploring productization of solutions[79] Employee and Governance - The group employed 1,610 long-term and contract employees across various regions, an increase from 1,596 in 2023[87] - The company has adopted the "Standards for Directors' Securities Transactions" as per the listing rules Appendix C3, confirming full compliance by all directors for the year ending December 31, 2025[95] - The company has adhered to the "Corporate Governance Code" outlined in the listing rules Appendix C1 throughout the year ending December 31, 2025[96]

Financial Performance - Revenue increased by 27% to RMB 707.6 million for the year ended December 31, 2025, compared to RMB 558.9 million in 2024[4] - Net loss for the year was RMB 14.6 million, an increase of 17% from RMB 12.4 million in 2024, primarily due to a decrease in the fair value of investments[4] - Non-HKFRS net profit for 2025 was RMB 13.7 million, up from RMB 7.0 million in 2024, excluding non-cash and one-off items[4] - The group reported a loss of RMB 14.6 million under Hong Kong Financial Reporting Standards for 2025, compared to a loss of RMB 12.4 million in 2024[17] - The company reported a net loss of RMB 14,551 thousand for 2025, compared to a net loss of RMB 12,443 thousand in 2024, indicating a deterioration in profitability[30] - The company reported a loss attributable to equity holders of RMB 14,551,000 in 2025, compared to a loss of RMB 12,443,000 in 2024, representing an increase of approximately 16.9%[62] Revenue Breakdown - Digital industrial business revenue grew by 34% to RMB 435.0 million, with profit increasing by 49% to RMB 28.0 million[11] - Digital life business revenue increased by 17% to RMB 272.6 million, with profit rising by 38% to RMB 12.5 million[12] - Revenue from related parties, specifically Hon Hai Precision Industry Co., Ltd. and its group companies, accounted for 50% of total revenue, amounting to RMB 352,220,000 for the fiscal year ending December 31, 2025[49] - Revenue from Taiwan increased significantly to RMB 101,023,000 in 2025 from RMB 62,625,000 in 2024, reflecting a growth of approximately 61.3%[48] - The digital industrial business generated revenue of RMB 434,976,000, while the digital lifestyle business contributed RMB 272,600,000 for the fiscal year ending December 31, 2025[44] Assets and Liabilities - Total assets decreased to RMB 594,222 thousand in 2025 from RMB 654,190 thousand in 2024, a decline of approximately 9.2%[31] - Current liabilities decreased to RMB 181,455 thousand in 2025 from RMB 222,778 thousand in 2024, a reduction of about 18.6%[32] - The company’s total liabilities decreased to RMB 189,415,000 in 2025 from RMB 229,277,000 in 2024, showing a reduction of approximately 17.4%[55] - The company’s equity attributable to owners decreased to RMB 404,807 thousand in 2025 from RMB 424,913 thousand in 2024, a decline of 4.7%[32] Cash Flow and Expenses - The company’s cash and cash equivalents decreased to RMB 112,857 thousand in 2025 from RMB 186,288 thousand in 2024, a decline of 39.3%[31] - Research and development expenses were reduced to RMB 893 thousand in 2025 from RMB 3,491 thousand in 2024, a decrease of 74.4%[29] - The company’s employee benefits expenses were RMB 55,576,000 in 2025, down from RMB 79,465,000 in 2024, representing a decrease of about 30.1%[57] - The financing income for 2025 was RMB 496,000, significantly lower than RMB 2,442,000 in 2024, indicating a decline of about 79.7%[58] - The company received government grants totaling RMB 108,000 in 2025, down from RMB 1,252,000 in 2024, a decrease of approximately 91.4%[56] Shareholder Returns - The board does not recommend any final dividend for the year[4] - No final dividend is recommended for the reporting year, consistent with the previous year[27] - The company did not recommend the payment of dividends for both 2025 and 2024[66] Corporate Governance - The company has complied with the corporate governance code as per the Hong Kong Stock Exchange regulations, with some deviations noted regarding the appointment of directors[67] - The board of directors consists of two executive directors, three non-executive directors, and three independent non-executive directors[75] Future Outlook - The company is optimistic about business opportunities in the US, Taiwan, Vietnam, and India markets for 2026[14] - The company expects to adopt the new Hong Kong Financial Reporting Standard No. 18 starting January 1, 2027, which will require retrospective application for comparative information[41] - The company is currently evaluating the impact of adopting other new accounting standards and amendments on its financial reporting[41] Inventory and Receivables - Inventory decreased to RMB 76.7 million from RMB 123.3 million in 2024, with inventory turnover days improving from 80 to 61 days[5] - Trade and lease receivables increased to RMB 252.0 million from RMB 190.6 million in 2024, with turnover days decreasing from 129 to 114 days[5] - Total accounts receivable increased to RMB 316,073,000 in 2025 from RMB 259,847,000 in 2024, reflecting a growth of approximately 21.6%[64] - The net accounts receivable after provisions for losses was RMB 252,048,000 in 2025, up from RMB 190,581,000 in 2024, an increase of about 32.3%[64]

Financial Performance - For the fiscal year ending December 31, 2025, the company reported revenue of RMB 790.5 million, an increase of 3.8% from RMB 761.8 million in 2024[3]. - The company's gross profit for the same period was RMB 580.7 million, reflecting a growth of 4.5% compared to RMB 555.9 million in the previous year[2]. - Net profit decreased by 26.2% to RMB 183.8 million from RMB 248.9 million in 2024, primarily due to impairment losses and fair value changes of investments[3]. - Adjusted net profit, excluding non-Hong Kong Financial Reporting Standards items, increased by 6.0% to RMB 298.5 million from RMB 281.7 million in 2024[3]. - The gross profit margin improved to 73.5%, an increase of 0.5 percentage points year-on-year[10]. - The group achieved a revenue of RMB 790.5 million in 2025, representing a growth of 3.8% compared to the previous year[10]. - The operating profit decreased to RMB 317,496,000 in 2025 from RMB 326,821,000 in 2024, indicating a decline of 2.0%[74]. - The pre-tax profit for 2025 was RMB 230,980,000, a decrease from RMB 302,733,000 in 2024, reflecting a decline of about 23.7%[97]. - Basic and diluted earnings per share for 2025 were RMB 0.32, compared to RMB 0.44 in 2024, representing a decrease of 27.3%[74]. - The company reported a foreign exchange loss of RMB 22,071,000 in 2025, compared to a gain of RMB 17,802,000 in 2024, impacting overall comprehensive income[75]. Product Development and Innovation - The company is expanding into new areas such as neurosurgery and brain-computer interfaces, with innovative solutions targeting conditions like hematoma and brain tumors[9]. - The company has developed several pioneering products, including the world's first stent system for intracranial atherosclerosis and the first domestically approved flow-diverting stent for treating cerebrovascular diseases[8]. - The group launched 6 new products registered with NMPA, enhancing its product matrix in the neuro-intervention field[11]. - The company has a total of 12 hemorrhagic stroke treatment products in its pipeline, with 8 products already approved for commercialization, including embolization coils and flow-diverting stents[23]. - The company is actively developing new products, with anticipated approvals for the Tubridge® series of flow-diverting stents expected in 2024 and 2026[22]. - The company has received breakthrough medical device designation from the FDA for its atherosclerosis narrowing products, allowing for expedited development[22]. Market Expansion and Sales - The overseas business experienced strong growth, with revenue increasing by 39.4% year-on-year, contributing to sales growth across various regions including Asia-Pacific, North America, Latin America, and Europe[3]. - The company holds the largest domestic market share in China's neuro-interventional medical device sector, with 10 core products commercialized in 36 countries, and overseas revenue accounting for 13% of total revenue[8]. - International business revenue reached RMB 104.9 million, a year-on-year increase of 39.4%, accounting for 13% of total revenue[18]. - The sales team expanded to cover nearly 3,800 hospitals, including over 2,100 tertiary hospitals and all top 100 stroke centers in China[12]. - The group supported over 66,700 neuro-intervention surgeries in 2025, a growth of over 30% year-on-year[12]. Financial Position and Assets - Total assets as of December 31, 2025, were RMB 1,498,693,000, an increase from RMB 1,370,075,000 in 2024[76]. - Non-current assets increased significantly to RMB 609,227,000 in 2025 from RMB 672,461,000 in 2024, primarily due to investments in property and equipment[76]. - Trade and other receivables rose to RMB 362,002,000 in 2025, up from RMB 176,991,000 in 2024, indicating improved collection efforts[76]. - The company holds structured deposits totaling RMB 406,779,000 as of December 31, 2025, with an expected annual return rate of 1.35%–1.86%[103]. - The total non-current assets in China amounted to RMB 486,272,000 as of December 31, 2025, compared to RMB 321,719,000 in 2024, reflecting a substantial increase of approximately 51.2%[88]. Research and Development - Research and development expenses for 2025 totaled RMB 108,768,000, down from RMB 150,523,000 in 2024, a reduction of about 27.8%[94]. - The company has established a research team of 113 members, with over 65% holding doctoral or master's degrees, focusing on innovative solutions in neurointerventional medical devices[65]. - The company aims to enhance its innovation capabilities and develop a comprehensive solution ecosystem for brain diseases, focusing on both internal R&D and external collaborations[71]. Corporate Governance and Shareholder Matters - The company has complied with all applicable corporate governance codes during the reporting period[151]. - The company proposed a final dividend of HKD 0.09 per share, subject to shareholder approval at the 2025 Annual General Meeting[157]. - The company plans to issue new shares under a scrip dividend scheme, pending approval from shareholders and the stock exchange[157]. - The share transfer registration will be suspended from July 6, 2026, to July 8, 2026, to determine eligibility for the proposed final dividend[160]. - The company expresses gratitude to shareholders, management, employees, business partners, and customers for their support and contributions[161].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 告 全 部 或 任 何 部 分 內 容 而 產 生 或 因 倚 賴 該 等 內 容 而 引 致 之 任 何 損 失 承 擔 任 何 責 任。 New Ray Medicine International Holding Limited （於百慕達註冊成立之有限公司） （股份代號：6108） 截至二零二五年十二月三十一日止年度 全年業績公告 二零二五年財務摘要 – 1 – • 截 至 二 零 二 五 年 十 二 月 三 十 一 日 止 年 度，本 集 團 錄 得 收 益 約130.4百萬港 元（二 零 二 四 年：約93.9百 萬 港 元），較 二 零 二 四 年 增 加 約38.9%。 • 截 至 二 零 二 五 年 十 二 月 三 十 一 日 止 年 度，本 集 團 毛 利 約 為16.1百 萬 港 元（二 零 二 四 年：約11.5百 萬 港 元），較 二 零 二 四 年 增 加 約40.0%。 • 截 至 二 零 二 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Chongqing Rural Commercial Bank Co., Ltd. 重慶農村商業銀行股份有限公司* （於中華人民共和國註冊成立的股份有限公司） （股份代號 : 3618） 2025年度業績公告 重慶農村商業銀行股份有限公司Chongqing Rural Commercial Bank Co., Ltd.*（「本行」） 之董事會（「董事會」）欣然宣佈本行及所屬子公司（「本集團」）截至2025年12月31日止十二 個月之經審計業績（「年度業績」）。本年度業績公告列載本集團截至2025年12月31日止十 二個月之年度報告全文，其內容是根據適用的香港聯合交易所有限公司（「香港聯交所」） 證券上市規則披露要求及按照國際財務報告準則編製。董事會審計委員會已審閱年度業 績。本年度業績公告於本行的網站(www.cqrcb.com)及香港聯交所的網站(www.hkexnews.hk) 發佈。本行將按本行H ...

Financial Performance - For the year ending December 31, 2025, the group reported revenue of approximately RMB 2,724.2 million, a slight decrease of about 4% compared to RMB 2,840.0 million in 2024[3]. - The group experienced a loss attributable to shareholders of RMB 1,371.2 million for the year, compared to a profit of RMB 28.9 million in 2024, primarily due to increased impairment losses and one-time transaction losses[3]. - The total revenue for property management services in 2025 was RMB 2,038.6 million, a decrease of approximately 2.1% from RMB 2,083.0 million in 2024[14]. - The company's basic and diluted loss per share for 2025 was RMB 1.158, compared to earnings of RMB 0.024 per share in 2024[85]. - The company reported a net loss of RMB 1,384,853,000 for the year, compared to a profit of RMB 28,590,000 in the previous year[85]. - The gross profit for 2025 was RMB 158,568,000, down from RMB 517,280,000 in 2024, indicating a significant decline in profitability[85]. - The income tax credit for 2025 was RMB 130.8 million, up from RMB 13.3 million in 2024, mainly due to the recognition of deferred tax assets from impairment losses[54]. - The cost of sales and services for 2025 is expected to rise by about 10% to RMB 2,565.6 million, up from RMB 2,322.7 million in 2024[40]. Property Management Operations - The number of contracted property management projects as of December 31, 2025, was 555, with a contracted area of 114.0 million square meters, representing a decrease of about 7% from the previous year[3]. - The area under management decreased by approximately 3% year-on-year to 89.4 million square meters, mainly due to the proactive exit from inefficient projects[3]. - Revenue from property management services was RMB 2,038.6 million, accounting for approximately 75% of the total revenue[13]. - The total contracted building area was 114.0 million square meters in 2025, a decrease of approximately 6.5% from 122.3 million square meters in 2024[16]. - The area under management was 89.4 million square meters in 2025, down about 3% from 92.5 million square meters in 2024[16]. - The company achieved an additional contracted building area of 7.1 million square meters in 2025, with approximately 94% coming from third-party sources[14]. - The revenue from the Beijing-Tianjin-Hebei region accounted for 32% of total revenue, amounting to RMB 663.4 million in 2025[18]. - The area of residential and other non-commercial property management projects contracted was 105.9 million square meters in 2025, a decrease of about 6% from 113.2 million square meters in 2024[20]. Strategic Initiatives - The company plans to enhance the quality of property management services and strengthen core business competitiveness to improve returns to shareholders[3]. - The company aims to focus on high-value areas and stable demand sectors, such as government and state-owned enterprises, to enhance its resilience against market cycles[3]. - The company plans to focus resources on major urban clusters to achieve sustainable growth and enhance market share through regional scale effects[33]. - The company aims to increase the proportion of residential acquisitions and strategically expand into industrial parks and public facilities to optimize revenue structure and enhance cyclical resilience[33]. - The company will implement a standardized market expansion system to promote efficient collaboration of internal resources and improve project management quality[33]. Financial Position and Liabilities - The total assets decreased to RMB 2,648,710,000 in 2025 from RMB 4,023,075,000 in 2024, reflecting a reduction of approximately 34.1%[87]. - The company had no borrowings as of December 31, 2025, maintaining a debt-to-equity ratio of zero[71]. - Current liabilities exceeded current assets by approximately RMB 58 million as of December 31, 2025[94]. - Total liabilities amounted to RMB 1.8986 billion as of December 31, 2025, compared to RMB 1.8865 billion in 2024, indicating a slight increase[94]. - The total equity and liabilities amounted to RMB 2.6487 billion as of December 31, 2025[94]. Employee and Operational Metrics - The company had 8,191 employees as of December 31, 2025, down from 8,585 employees in 2024, primarily due to business strategy optimization[79]. - Employee benefit expenses increased to RMB 901,274,000 in 2025, up from RMB 871,281,000 in 2024, reflecting a growth of 3.4%[114]. - The company is enhancing its operational efficiency and cyclical resilience through refined management and resource integration in non-owner value-added services[31]. Market and Competitive Landscape - The property management industry is expected to face intense competition in the stock market, but new structural growth momentum is anticipated as market demands evolve and policies continue to support the sector[8]. - The company is exploring potential acquisitions to further strengthen its market position[155]. - Market expansion efforts have led to a 30% increase in market share in the Asia-Pacific region[155]. Corporate Governance and Compliance - The company has applied the principles of the corporate governance code throughout the year ending December 31, 2025, with certain deviations disclosed[144]. - The roles of the co-chairman and CEO were separated after March 24, 2025, to comply with corporate governance code requirements[145]. - The company secretary's appointment was approved through a written resolution instead of a board meeting, which the company considers an effective and appropriate process[145]. Dividends and Shareholder Information - The board proposed a final cash dividend of RMB 0.0107 per share, equivalent to HKD 0.0122 per share[3]. - The proposed final dividend for the year ending December 31, 2025, is RMB 0.0107 per share, equivalent to HKD 0.0122 per share, subject to shareholder approval at the annual general meeting on May 21, 2026[139]. - The total dividend paid for the fiscal year 2024 was RMB 31,850,000, with no dividends declared for 2025[124].

Financial Performance - The total assets of Chengdu Siwi Science and Technology Company Limited as of December 31, 2025, amounted to RMB 1,036,854,668.93, compared to RMB 1,004,717,519.26 at the end of the previous year, reflecting an increase of approximately 3.2%[5] - Total revenue for the current period reached ¥366,043,095.86, a 21.2% increase from ¥302,066,668.88 in the same period last year[10] - Net profit for the current period was ¥4,152,475.79, significantly up from ¥1,241,457.89 year-over-year, indicating a growth of 234.5%[13] - Total comprehensive income attributable to the parent company reached CNY 2,982,510.29, up from CNY 1,149,744.65 in the same period last year, representing an increase of 159.5%[17] - The company reported a retained earnings of CNY 4,003,849.38, a significant recovery from a deficit of CNY -272,912,958.36 in the prior year[8] Assets and Liabilities - The company's current assets totaled RMB 798,749,601.04, up from RMB 762,450,955.52 in the previous year, indicating a growth of about 4.8%[4] - Non-current assets decreased slightly to RMB 238,105,067.89 from RMB 242,266,563.74, representing a decline of approximately 1.4%[5] - Total liabilities were CNY 171,593,907.36, an increase from CNY 137,858,801.05 compared to the previous year[9] - Total liabilities and equity amounted to CNY 1,036,854,668.93, an increase from CNY 1,004,717,519.26 year-over-year[8] - The asset-liability ratio rose to 16.55%, up 2.83 percentage points from 13.72% the previous year[103] Revenue and Costs - Total operating costs amounted to ¥363,666,444.72, compared to ¥304,066,172.35 in the previous year, reflecting a 19.6% increase[10] - Revenue from sales of goods and services amounted to CNY 289,868,595.61, down from CNY 356,607,753.39 in the same period last year, a decrease of 18.7%[19] - Total costs for the current period were 294,119,787.88, up from 238,929,176.04, which is an increase of approximately 23.2%[51] - Management expenses totaled 43,344,161.25, slightly decreasing from 44,618,379.45 year-over-year, indicating a reduction of about 2.9%[52] Cash Flow - Operating cash inflow from business activities was CNY 302,081,808.50, a decrease from CNY 368,596,208.73 year-on-year, indicating a decline of 18%[19] - The company reported a total cash outflow from operating activities of CNY 282,470,732.57, down from CNY 348,321,299.76 in the previous year, indicating improved cash management[21] - The cash flow from financing activities shows a net outflow of CNY -4,674,284.00, compared to a smaller outflow of CNY -512,440.03 in the same period last year, reflecting increased financing costs[25] - The company’s operating cash flow for the current period is CNY 86,125,476.16, compared to a negative cash flow of CNY -46,239,491.26 in the same period last year, indicating a significant improvement[21] Research and Development - The company is actively pursuing new product development and market expansion strategies, although specific details were not provided in the financial documents[4] - Research and development expenses increased to ¥16,776,583.28 from ¥15,077,845.62, marking an increase of 11.3%[10] - The company is investing in technology research and development to enhance its product offerings and competitive edge[28] - The company filed for 18 patents and was granted 7 invention patents, reflecting its commitment to innovation[93] Market Strategy and Future Outlook - Future outlook includes a focus on enhancing operational efficiency and exploring potential mergers and acquisitions to drive growth[4] - The company plans to expand its market presence and invest in new technologies to drive future growth[12] - Future guidance indicates a cautious outlook due to market conditions, with expectations for moderate growth in the upcoming quarters[17] - The company is exploring potential mergers and acquisitions to enhance its competitive position in the market, although specific targets were not mentioned[17] Corporate Governance and Compliance - The audit committee has reviewed the financial statements for the year and confirmed compliance with applicable accounting standards and legal requirements[136] - The company emphasizes its commitment to high standards of corporate governance to ensure transparency and protect shareholder interests[134] - All directors and supervisors have fully complied with the standards for securities trading as per the listing rules during the year[135] Employee and Management Compensation - Total compensation for key management personnel was 3,180,667.09, a decrease from 3,341,139.42 in the previous year, reflecting a decline of approximately 4.8%[72] - The total compensation for the board of directors, including salaries, bonuses, and other benefits, was 612,836.04, compared to 891,631.90 in the previous year, showing a significant decrease of about 31.1%[73] - The total compensation for the top five non-director employees amounted to $2,567,831.05, an increase from $2,449,507.52 in the same period last year, representing a growth of approximately 4.8%[75] Related Party Transactions - The company reported a total related party transaction amount of 96,149,105.43 CNY in the current period, compared to 95,674,852.75 CNY in the same period last year, indicating a slight increase[68] - The accounts receivable from related parties totaled $38,954,085.12, with a bad debt provision of $749,650.94, compared to $71,105,160.13 and $910,406.31 respectively from the previous year[76] - The accounts payable to related parties reached $15,709,494.97, a decrease from $17,879,466.83 in the previous year, indicating a reduction of approximately 12.1%[78] Risk Management - Risk management will focus on balancing risk and return, with five key risks identified for close monitoring and control[120] - Market risks include high product homogeneity and industry downturns, with strategies to expand new customer bases and improve market share[121] - The company is implementing a plan to manage accounts receivable more effectively, including regular reconciliations and legal measures if necessary[125]